Edgewise Therapeutics, Inc. (EWTX) Social Stream
Edgewise Therapeutics Inc (EWTX) Price Targets From Analysts
Use the tables below to see what analysts covering Edgewise Therapeutics Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
EWTX's average price target has moved down $2 over the prior 44 weeks.
EWTX reports an average of 70% for its upside potential over the past 44 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
EWTX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
EWTX's average broker recommendation rating improved by 0.33 over the prior 123 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for EWTX as an investment opportunity.
- EWTX has a higher upside potential (average analyst target price relative to current price) than 270.12% of all US stocks.
- In terms of how Edgewise Therapeutics Inc fares relative to all US stocks, note that its number of analysts covering the stock is greater than 33.42% of that group.
- In terms of how Edgewise Therapeutics Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than 66.16% of that group.
- To contextualize these metrics, consider that out of stocks in the small market cap category, Edgewise Therapeutics Inc's average analyst price target is greater than 215.62% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Edgewise Therapeutics Inc are EVLO, ETNB, and EPIX.
Is EWTX a Buy, Hold or Sell? See the POWR Ratings now!